- $106.31m
- $86.28m
- $19.61m
Brief: iCAD Reports Financial Results For First Quarter Ended March 31, 2022
Icad Inc Expected To Post A Loss Of 12 Cents A Share: Earnings Preview
Icad Inc Expected To Post A Loss Of 12 Cents A Share: Earnings Preview
Brief: Icad Announces Q1 Revenue And CFO Transition
Icad Inc Reports Results For The Quarter Ended In December: Earnings Summary
Brief: ICAD Reports Financial Results For Fourth Quarter And Year Ended December 31, 2021
Icad Inc Expected To Post A Loss Of 12 Cents A Share: Earnings Preview
Brief: ICAD Appoints New Members To Its Board Of Directors
Icad Slumps To Near 2: year low after co forecasts Q4 sales fall
Brief: iCAD Inc Appoints Stacey Stevens As Co's President And Chief Executive Officer
Icad Inc Reports Results For The Quarter Ended In September: Earnings Summary
Brief: ICAD Inc Reports Q3 Loss Per Share $0.09
Brief: iCAD Launches Revolutionary Short-Term Personalized Risk Assessment Solution For 3D Mammography
Brief: ICAD's Xoft Brain IORT Shows Improvement In Survival In Recurrent Glioblastoma
Brief: Icad Inc Says Charles Carter Was Appointed Chief Financial Officer
Icad Inc Reports Results For The Quarter Ended In June: Earnings Summary
Icad Inc Expected To Post A Loss Of 7 Cents A Share: Earnings Preview
Brief: Icad’S Profound Ai For Digital Breast Tomosynthesis Version 3.0 Receives CE Mark Approval
Brief: Icad Signs Global Distribution Agreement With Sectra